Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mallinckrodt Plc (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 787,014
  • Shares Outstanding, K 83,814
  • Annual Sales, $ 3,216 M
  • Annual Income, $ -3,607,000 K
  • 60-Month Beta 2.39
  • Price/Sales 0.24
  • Price/Cash Flow 0.51
  • Price/Book 0.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 2.13
  • Number of Estimates 10
  • High Estimate 2.25
  • Low Estimate 2.04
  • Prior Year 1.78
  • Growth Rate Est. (year over year) +19.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.42 +14.96%
on 05/31/19
10.54 -8.16%
on 06/05/19
-3.35 (-25.71%)
since 05/20/19
3-Month
8.42 +14.96%
on 05/31/19
24.12 -59.87%
on 03/21/19
-13.98 (-59.09%)
since 03/20/19
52-Week
8.42 +14.96%
on 05/31/19
36.65 -73.59%
on 08/20/18
-10.51 (-52.06%)
since 06/20/18

Most Recent Stories

More News
Mallinckrodt Down After Agreement with DOJ for Litigation

Mallinckrodt (MNK) expects to pay $15.4 million to DOJ in relation with the Questcor litigation.

CELG : 98.20 (+0.38%)
MNK : 9.62 (+2.45%)
RHHBY : 35.8100 (+1.65%)
BMY : 48.99 (+0.78%)
After Yesterday's Decline of 3.80%, Mallinckrodt Offers Investors Better Value

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $8.60 to a high of $8.85. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $8.62 on...

MNK : 9.62 (+2.45%)
Mallinckrodt Announces Agreement In Principle With U.S. Department Of Justice On Legacy Questcor Sales And Marketing Activities; Responds To Government Civil Litigation Involving Legacy Questcor Charitable Foundation Activities

Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, today reported the company has reached an agreement in principle with the U.S. Department of Justice (DOJ) to resolve the previously...

MNK : 9.62 (+2.45%)
Cara Shares Up on Positive Phase III Data for Itchiness Drug

Cara (CARA) reports positive top-line data from phase III study of Korsuva injection in hemodialysis patients with moderate-to-severe chronic kidney disease-related pruritus.

CARA : 20.01 (+1.42%)
MNK : 9.62 (+2.45%)
PCRX : 43.83 (+0.46%)
FMS : 40.07 (+1.49%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (MDCO , MNK , OMER , LCI , PRGO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MDCO : 35.59 (+1.02%)
MNK : 9.62 (+2.45%)
OMER : 16.78 (+0.90%)
Shares of MNK Down 51.2% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on April 18th, 2019 at $18.66. In approximately 1 month, Mallinckrodt has returned 51.22% as of today's recent price of $9.10.

MNK : 9.62 (+2.45%)
Mallinckrodt to Spin Off Specialty Generics Unit, Shares Down

Mallinckrodt (MNK) will spin-off its Specialty Generics business to its shareholders.

ANIK : 40.11 (+0.25%)
AXGT : 5.72 (+2.51%)
AGTC : 3.83 (-1.29%)
MNK : 9.62 (+2.45%)
Mallinckrodt (MNK) Down After Filing Suit Against HHS and CMS

Mallinckrodt (MNK) declines after filing suit against HHS and CMS for the protection of Medicaid patient access to Acthar.

CELG : 98.20 (+0.38%)
MNK : 9.62 (+2.45%)
RHHBY : 35.8100 (+1.65%)
BMY : 48.99 (+0.78%)
LOST MONEY IN MALLINCKRODT? Gibbs Law Group Investigates Potential Securities Claims on Behalf of Investors

Mallinckrodt plc shares have declined by nearly 38% in 2019 due to issues with health regulators and accusations of kickbacks. Gibbs Law Group is investigating a Mallinckrodt class...

MNK : 9.62 (+2.45%)
AutoZone, Qualcomm rise; Kohl's, J.C. Penney fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

EV : 42.55 (+1.29%)
DY : 57.00 (+2.04%)
JCP : 1.24 (+2.48%)
KSS : 46.85 (-0.09%)
MNK : 9.62 (+2.45%)
CIR : 45.81 (-2.09%)
CR : 81.59 (+1.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade MNK with:

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 9.83
1st Resistance Point 9.61
Last Price 9.62
1st Support Level 9.20
2nd Support Level 9.00

See More

52-Week High 36.65
Fibonacci 61.8% 25.87
Fibonacci 50% 22.53
Fibonacci 38.2% 19.20
Last Price 9.62
52-Week Low 8.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar